Lantern Pharma, Inc. (LTRN)
1.80
-0.04
(-2.17%)
USD |
NASDAQ |
Sep 09, 12:39
Lantern Pharma Total Liabilities (Quarterly) : 11.82M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.82M |
| March 31, 2026 | 3.777M |
| December 31, 2025 | 4.505M |
| September 30, 2025 | 4.04M |
| June 30, 2025 | 4.898M |
| March 31, 2025 | 4.320M |
| December 31, 2024 | 4.384M |
| September 30, 2024 | 3.695M |
| June 30, 2024 | 4.656M |
| March 31, 2024 | 3.969M |
| December 31, 2023 | 2.740M |
| September 30, 2023 | 2.360M |
| June 30, 2023 | 3.167M |
| Date | Value |
|---|---|
| March 31, 2023 | 2.934M |
| December 31, 2022 | 2.798M |
| September 30, 2022 | 3.139M |
| June 30, 2022 | 5.304M |
| March 31, 2022 | 3.087M |
| December 31, 2021 | 2.379M |
| September 30, 2021 | 1.878M |
| June 30, 2021 | 2.819M |
| March 31, 2021 | 0.773M |
| December 31, 2020 | 0.6608M |
| September 30, 2020 | 0.9231M |
| June 30, 2020 | 2.385M |
| March 31, 2020 | 0.5015M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.641M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.602M |
| Shareholders Equity (Quarterly) | -3.217M |
| Debt to Equity Ratio | -0.0123 |
| Current Ratio | 1.957 |
| Net Debt Paydown Yield | 0.06% |